<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02666456</url>
  </required_header>
  <id_info>
    <org_study_id>DOLORisk WP4</org_study_id>
    <nct_id>NCT02666456</nct_id>
  </id_info>
  <brief_title>The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain</brief_title>
  <official_title>DOLORisk: Understanding Risk Factors and Determinants for Neuropathic Pain - The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Kiel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kiel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cross-sectional and longitudinal analysis of the somatosensory phenotype, assessed by
      quantitative sensory testing (QST) and Information obtained by questionnaires to detect risk
      factors for neuropathic pain development and chronification in painless and chronic pain
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2016</start_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Somatosensory phenotype detected by quantitative sensory testing (QST)</measure>
    <time_frame>Single assessment at baseline (cross-sectional study). Report of complete cohort data at study completion</time_frame>
    <description>The somatosensory phenotype will be assessed by quantitative sensory testing (QST) once at baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of neuropathic pain: Development and chronification of neuropathic pain detected by DN4 questionnaire</measure>
    <time_frame>Assessment of change of neuropathic pain from baseline and 6 months after study enrollment (longitudinal study). Report of complete cohort data at study completion.</time_frame>
    <description>Assessment with DN4 pain questionnaire</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Neuropathic Pain</condition>
  <condition>Polyneuropathy</condition>
  <condition>Peripheral Nerve Injury</condition>
  <arm_group>
    <arm_group_label>Cross-sectional cohort</arm_group_label>
    <description>Patients with chronic peripheral neuropathic pain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Longitudinal cohort</arm_group_label>
    <description>Painless patients before and after potential chronic neuropathic pain-inducing interventions (chemotherapy, Operation)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>QST, Questionnaires</intervention_name>
    <description>Assessment of sensory phenotype by QST and questionnaires</description>
    <arm_group_label>Cross-sectional cohort</arm_group_label>
    <arm_group_label>Longitudinal cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Painless patients and patients with chronic peripheral neuropathic pain.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic peripheral neuropathic pain or

          -  Painless Patient with risk to develop neuropathic pain (post-surgery,
             chemotherapy-induced)

        Exclusion Criteria:

          -  Minors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Andreas Binder, MD</last_name>
    <phone>+49 431 597</phone>
    <phone_ext>8822</phone_ext>
    <email>andreas.binder@uksh.de</email>
  </overall_contact>
  <link>
    <url>http://cordis.europa.eu/project/rcn/193238_en.html</url>
    <description>Funding source</description>
  </link>
  <link>
    <url>http://www.ndcn.ox.ac.uk/research/neural-injury-group/research-projects/dolorisk</url>
    <description>WEbsite</description>
  </link>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2016</study_first_submitted>
  <study_first_submitted_qc>January 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2016</study_first_posted>
  <last_update_submitted>January 25, 2016</last_update_submitted>
  <last_update_submitted_qc>January 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Kiel</investigator_affiliation>
    <investigator_full_name>Andras Binder</investigator_full_name>
    <investigator_title>PD Dr. med.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Polyneuropathies</mesh_term>
    <mesh_term>Peripheral Nerve Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

